VIVEX Biologics Announces Presentation of Clinical Results of VIA Disc® at The Orthobiologic Institute (TOBI) Virtual Symposium
11 juin 2020 16h51 HE
|
Vivex Biologics, Inc.
First large randomized controlled trial to demonstrate clinically significant and objective benefit from treating the disc, the most common source of back pain Initial safety results recently...
VIVEX Biologics Announces Presentation of Clinical Results of VIA Disc® During Webinar Series Hosted by The American Society of Pain & Neuroscience (ASPN)
19 mai 2020 10h17 HE
|
Vivex Biologics, Inc.
First large randomized controlled trial to demonstrate clinically significant and objective benefit from treating the disc, the most common source of back pain Presentation to be part of continuing...
VIVEX Biologics Publishes Initial Clinical Results of VIA Disc in The International Journal of Spine Surgery
30 avr. 2020 10h17 HE
|
Vivex Biologics, Inc.
First-ever published 12-month results from Level 1 intradiscal study for treating patients with one or two level symptomatic degenerative disc disease Early evidence suggests greater than 70%...
VIVEX Biologics, Inc. Announces Multiple Presentations at the International Society for the Advancement of Spine Surgery (ISASS) 2020 Meeting
20 févr. 2020 10h17 HE
|
Vivex Biologics, Inc.
Industry-leading KOLs to present data from studies of multiple VIVEX technologies Presentations to showcase VIVEX products’ capacities to promote healing and bone fusion in certain spinal disorders ...
Vivex Biologics, Inc. Appoints Chad Kolean as Chief Financial Officer
12 févr. 2020 10h17 HE
|
Vivex Biologics, Inc.
ATLANTA and MIAMI, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced, biologically engineered...
Vivex Biologics, Inc. to Host Panel Discussion Luncheon and Present Data from the Company’s VAST Trial at the Annual World Stem Cell Summit
21 janv. 2020 09h31 HE
|
Vivex Biologics, Inc.
ATLANTA and MIAMI, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatment options, today...